The article presents a report which suggests that inhibiting histone deacetylase 2 (HDAC2) could be therapeutic in schizophrenia. It notes that acetylation is among the post-translational modifications of histone proteins that render genes more available for transcription by chromatin remodeling. The study represents a rapidly growing area of epigenetics research related to adult nervous system plasticity including drug-induced plasticity.